<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Clin (Engl Ed)</journal-id><journal-id journal-id-type="iso-abbrev">Med Clin (Engl Ed)</journal-id><journal-title-group><journal-title>Medicina Clinica (English Ed.)</journal-title></journal-title-group><issn pub-type="epub">2387-0206</issn><publisher><publisher-name>Elsevier Espa&#x000f1;a, S.L.U.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7495144</article-id><article-id pub-id-type="publisher-id">S2387-0206(20)30409-5</article-id><article-id pub-id-type="doi">10.1016/j.medcle.2019.05.038</article-id><article-categories><subj-group subj-group-type="heading"><subject>Scientific Letter</subject></subj-group></article-categories><title-group><article-title>Viral etiology of exacerbations of patients with chronic obstructive pulmonary disease during the winter season<sup><xref ref-type="fn" rid="d33e177">&#x02606;</xref></sup></article-title><trans-title-group xml:lang="es"><trans-title>Etiolog&#x000ed;a viral de las exacerbaciones de los pacientes con enfermedad pulmonar obstructiva cr&#x000f3;nica en la &#x000e9;poca invernal</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Reina</surname><given-names>Jordi</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Sala</surname><given-names>Ernest</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Fraile</surname><given-names>Pablo</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><aff id="aff0005"><label>a</label>Unidad de Virolog&#x000ed;a, Servicio de Microbiolog&#x000ed;a, Hospital Universitario Son Espases, Palma de Mallorca, Spain</aff><aff id="aff0010"><label>b</label>Servicio de Neumolog&#x000ed;a, Hospital Universitario Son Espases, Palma de Mallorca, Spain</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author.</corresp></author-notes><pub-date pub-type="pmc-release"><day>17</day><month>9</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="epub"><day>17</day><month>9</month><year>2020</year></pub-date><permissions><copyright-statement>&#x000a9; 2019 Elsevier Espa&#x000f1;a, S.L.U. All rights reserved.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Elsevier Espa&#x000f1;a, S.L.U.</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><body><p content-type="salutation">Dear Editor,</p><p id="par0005">Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory process that alters the patient's functional capacity. It is estimated to be the fourth leading cause of death worldwide, affecting 2.4% of the population.<xref rid="bib0030" ref-type="bibr"><sup>1</sup></xref> COPD exacerbations (COPDE) constitute the main complications of this disease since they deteriorate lung function. These acute processes have multifactorial causes, including viral infections, especially during the winter season.<xref rid="bib0030" ref-type="bibr">1</xref>, <xref rid="bib0035" ref-type="bibr">2</xref>
</p><p id="par0010">Chronic inflammation caused by viral infection and stimulation of IL-8 and other cytokines appear to be the cause of COPDE and lung lesions.<xref rid="bib0040" ref-type="bibr"><sup>3</sup></xref> The viral impact in these processes has been underestimated until now due to the detection techniques used; the current use of molecular techniques has demonstrated the leading role of viruses in these episodes. With this technology, different studies have demonstrated viral infection in between 30 and 40% of COPDE cases, primarily involving rhinovirus, influenza and respiratory syncytial virus (RSV).<xref rid="bib0040" ref-type="bibr">3</xref>, <xref rid="bib0045" ref-type="bibr">4</xref>
</p><p id="par0015">The incorporation of molecular techniques in the diagnosis of viral infections has allowed us to study their participation in acute COPDE cases.</p><p id="par0020">We report a prospective study conducted during the period with the highest prevalence of this type of infection (from October 2018 to February 2019). One hundred and eighty-seven patients (79% men) who came to the emergency department with an exacerbation (cough, expectoration and respiratory distress) of their previously diagnosed COPD were analysed during the study period.</p><p id="par0025">A single throat swab culture was performed in each patient to detect bacteria and viruses. The viruses were studied using a commercial real-time RT-PCR (Allplex Respiratory Assay, Seegen, South Korea) that simultaneously and differentially detected 16 different viruses.</p><p id="par0030">One hundred and four (104) positive samples (55.6%) were detected in the 187 patients, of which 78 (41.7%) corresponded to viruses alone, 19 (10.1%) to bacteria alone, and 7 (3.7%) to viruses and bacteria together. That is, viruses represented 45.4% (85 cases) of all respiratory processes in these patients. Differences in viral aetiology were observed in each of the months studied: with 36.6% in November and 69.7% in December. Similarly, the percentage of viral infections as the sole cause of COPDE has also fluctuated: it was 60% in October and 94.4% in February.</p><p id="par0035">The main viruses detected have been rhinovirus (30.5%), influenza A (H3N2) (28.2%), RSV-B (22.3%), coronavirus (16.4%), adenovirus (1.1%) and metapneumovirus (1.1%). The bacteria detected were mainly <italic>P. aeruginosa</italic> and <italic>H. influenzae</italic> and, of the 7 virus&#x02013;bacteria associations, rhinovirus represented the majority of them (57%). Five patients (5.8%) with influenza A (H3N2) infection required admission to the ICU; no patient died as a result of viral infection.</p><p id="par0040">A recent meta-analysis on the prevalence of viral infections in COPDE showed that a virus can be detected in up to 50% of cases if molecular techniques are used.<xref rid="bib0030" ref-type="bibr">1</xref>, <xref rid="bib0035" ref-type="bibr">2</xref>, <xref rid="bib0040" ref-type="bibr">3</xref>, <xref rid="bib0045" ref-type="bibr">4</xref> In our study, positive results for viruses reached a total of 45.4%, a value that is within the range reported. Our study simultaneously analysed the presence of bacteria, although they have represented only 10.1% of the cases. Whether they are simple colonizers or true pathogens cannot be determined.<xref rid="bib0035" ref-type="bibr">2</xref>, <xref rid="bib0050" ref-type="bibr">5</xref>
</p><p id="par0045">Rhinoviruses have been the most commonly detected viruses, which coincides with other studies that estimate them at up to 58%,<xref rid="bib0030" ref-type="bibr">1</xref>, <xref rid="bib0035" ref-type="bibr">2</xref> although in the winter season there is a high circulation of these viruses associated with the common cold. As expected, influenza viruses, in this case circulating A (H3N2), and RSV have been the cause of 50.5% of COPDE cases. Viral aetiology distribution data similar to ours have already been described, although with variations depending on the type of influenza circulating in a given winter epidemic.<xref rid="bib0030" ref-type="bibr">1</xref>, <xref rid="bib0035" ref-type="bibr">2</xref>, <xref rid="bib0040" ref-type="bibr">3</xref>, <xref rid="bib0045" ref-type="bibr">4</xref>
</p><p id="par0050">Rapid identification of the viral aetiology of COPDE cases avoids the unnecessary administration of antibiotics and anticipates a good prognosis. Of the main viruses involved, only influenza could be prevented by systematically vaccinating these patients each season.</p><sec id="sec0005"><title>Conflict of interest</title><p id="par0055">The authors have no conflict of interest.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0030"><label>1</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Jafarinejad</surname><given-names>H.</given-names></name><name><surname>Moghoofei</surname><given-names>M.</given-names></name><name><surname>Mostafaei</surname><given-names>S.</given-names></name><name><surname>Salimian</surname><given-names>J.</given-names></name><name><surname>Jamalkandi</surname><given-names>S.A.</given-names></name><name><surname>Ahmadi</surname><given-names>A.</given-names></name></person-group><article-title>Worldwide prevalence of viral infection in AECOPD patients: a meta-analysis</article-title><source>Microbial Path</source><volume>115</volume><year>2017</year><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.10.021</pub-id></element-citation></ref><ref id="bib0035"><label>2</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Wedzicha</surname><given-names>J.A.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Mackay</surname><given-names>A.J.</given-names></name></person-group><article-title>Acute COPD exacerbations</article-title><source>Clin Chest Med</source><volume>35</volume><year>2014</year><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.ccm.201311001</pub-id><pub-id pub-id-type="pmid">24507843</pub-id></element-citation></ref><ref id="bib0040"><label>3</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Almansa</surname><given-names>R.</given-names></name><name><surname>Socias</surname><given-names>D.</given-names></name><name><surname>Andaluz-Ojeda</surname><given-names>I.</given-names></name><name><surname>Martin-Loeches</surname><given-names>F.</given-names></name><name><surname>Bobillo</surname><given-names>J.</given-names></name><name><surname>Blanco</surname><given-names>J.</given-names></name></person-group><article-title>Viral infection is associated with an inceased proinflammatory response in chronic obstructuve pulmonary disease</article-title><source>Viral Immunol</source><volume>25</volume><year>2012</year><fpage>249</fpage><lpage>253</lpage><pub-id pub-id-type="other">10.1089/vim. 2011.0095</pub-id><pub-id pub-id-type="pmid">22746693</pub-id></element-citation></ref><ref id="bib0045"><label>4</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Britto</surname><given-names>C.J.</given-names></name><name><surname>Brady</surname><given-names>V.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>de la Cruz</surname><given-names>C.S.</given-names></name></person-group><article-title>Respiratory viral infections in chronic lung diseases</article-title><source>Clin Chest Med</source><volume>38</volume><year>2017</year><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.ccm.2016.11.014</pub-id><pub-id pub-id-type="pmid">28159164</pub-id></element-citation></ref><ref id="bib0050"><label>5</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Jankauskaite</surname><given-names>L.</given-names></name><name><surname>Miseviciene</surname><given-names>V.</given-names></name><name><surname>Vaideliene</surname><given-names>L.</given-names></name><name><surname>Kevalas</surname><given-names>R.</given-names></name></person-group><article-title>Lower airway viirology in health and disease. From invaders to symbionts</article-title><source>Medicina</source><volume>54</volume><year>2018</year><fpage>72</fpage><pub-id pub-id-type="doi">10.3390/medicina54050072</pub-id></element-citation></ref></ref-list><fn-group><fn id="d33e177"><label>&#x02606;</label><p id="npar0005">Please cite this article as: Reina J, Sala E, Fraile P. Etiolog&#x000ed;a viral de las exacerbaciones de los pacientes con enfermedad pulmonar obstructiva cr&#x000f3;nica en la &#x000e9;poca invernal. Med Clin (Barc). 2020. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.medcli.2019.05.025" id="intr0005">https://doi.org/10.1016/j.medcli.2019.05.025</ext-link></p></fn></fn-group></back></article>